Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Carcinoma In Situ 1

Interventions

Fulvestrant 81 Letrozole 74 Paclitaxel 73 pembrolizumab 68 Specimen Handling 63 Trastuzumab 62 Carboplatin 55 Magnetic Resonance Spectroscopy 50 ribociclib 48 Capecitabine 48 Anastrozole 45 palbociclib 44 pertuzumab 43 Cyclophosphamide 39 Tamoxifen 38 exemestane 37 abemaciclib 37 Biopsy 36 trastuzumab deruxtecan 31 Docetaxel 28 Taxes 27 Radiotherapy 26 Gemcitabine 25 Surveys and Questionnaires 24 Standard of Care 23 130-nm albumin-bound paclitaxel 23 Blood Specimen Collection 22 olaparib 21 sacituzumab govitecan 20 eribulin 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Starch × Breast × 90 days × Clear all

NCT07443943 2026-04-24

AIMSS-RPS

University of Michigan Rogel Cancer Center

Phase 2 Recruiting

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡